SHU 555C

Drug Profile

SHU 555C

Alternative Names: Ferumoxtran-10 - Bayer Schering Pharma; SH U 555 C; Supravist; Ultrasmall Superparamagnetic Ironoxide; USPIO

Latest Information Update: 13 Jul 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bayer Schering Pharma
  • Class Contrast media; Ferric compounds; Glucans; Oxides
  • Mechanism of Action Magnetic resonance imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Ischaemic heart disorders

Most Recent Events

  • 13 Jul 2010 No development reported - Preregistration for Ischaemic heart disorders diagnosis in Sweden (IV)
  • 21 Oct 2009 Regulatory discussions are ongoing with SHU 555C
  • 31 Dec 2006 Preregistration for Ischaemic heart disorders (diagnosis) in Sweden (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top